William Blair Investment Management LLC Invests $78.89 Million in Merit Medical Systems, Inc. $MMSI

William Blair Investment Management LLC purchased a new position in Merit Medical Systems, Inc. (NASDAQ:MMSI) in the 2nd quarter, HoldingsChannel.com reports. The firm purchased 1,137,790 shares of the medical instruments supplier’s stock, valued at approximately $78,894,000.

A number of other large investors also recently bought and sold shares of the business. Lido Advisors LLC boosted its stake in Merit Medical Systems by 3.8% during the fourth quarter. Lido Advisors LLC now owns 3,836 shares of the medical instruments supplier’s stock worth $324,000 after acquiring an additional 140 shares in the last quarter. AMI Asset Management Corp increased its stake in shares of Merit Medical Systems by 0.8% during the first quarter. AMI Asset Management Corp now owns 21,818 shares of the medical instruments supplier’s stock valued at $1,504,000 after purchasing an additional 168 shares in the last quarter. Maryland State Retirement & Pension System lifted its holdings in shares of Merit Medical Systems by 2.1% during the fourth quarter. Maryland State Retirement & Pension System now owns 8,693 shares of the medical instruments supplier’s stock valued at $766,000 after purchasing an additional 180 shares during the last quarter. CANADA LIFE ASSURANCE Co lifted its holdings in shares of Merit Medical Systems by 0.4% during the third quarter. CANADA LIFE ASSURANCE Co now owns 50,667 shares of the medical instruments supplier’s stock valued at $4,095,000 after purchasing an additional 189 shares during the last quarter. Finally, Oregon Public Employees Retirement Fund lifted its holdings in shares of Merit Medical Systems by 1.5% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 13,562 shares of the medical instruments supplier’s stock valued at $1,195,000 after purchasing an additional 200 shares during the last quarter. 99.66% of the stock is owned by hedge funds and other institutional investors.

Merit Medical Systems Price Performance

Shares of NASDAQ MMSI opened at $90.78 on Friday. The firm has a market cap of $5.42 billion, a P/E ratio of 37.51, a PEG ratio of 2.27 and a beta of 0.49. Merit Medical Systems, Inc. has a twelve month low of $59.74 and a twelve month high of $94.75. The company has a quick ratio of 2.79, a current ratio of 4.20 and a debt-to-equity ratio of 0.44. The company has a 50 day moving average of $77.41 and a 200 day moving average of $72.57.

Merit Medical Systems (NASDAQ:MMSI) last issued its earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 EPS for the quarter, beating the consensus estimate of $0.96 by $0.23. The business had revenue of $418.84 million for the quarter, compared to the consensus estimate of $405.25 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.The company’s revenue was up 9.5% compared to the same quarter last year. During the same period last year, the business posted $1.01 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. As a group, research analysts expect that Merit Medical Systems, Inc. will post 3.81 EPS for the current fiscal year.

Analysts Set New Price Targets

MMSI has been the topic of several recent research reports. Raymond James Financial restated an “outperform” rating and issued a $100.00 price target on shares of Merit Medical Systems in a research note on Friday, July 31st. Bank of America raised their price target on Merit Medical Systems from $92.00 to $97.00 and gave the company a “neutral” rating in a report on Thursday, August 13th. JPMorgan Chase & Co. lifted their price target on Merit Medical Systems from $77.00 to $95.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. Robert W. Baird set a $98.00 price target on shares of Merit Medical Systems in a research note on Friday, July 31st. Finally, Canaccord Genuity Group raised their price objective on shares of Merit Medical Systems from $85.00 to $94.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Eight research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Merit Medical Systems presently has a consensus rating of “Moderate Buy” and an average target price of $100.00.

Merit Medical Systems Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.